Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare
,
HHS
,
Pfizer
,
Bristol Myers Squibb
,
Eli Lilly
,
Boehringer Ingelheim
,
AstraZeneca
,
AbbVie
,
Novo Nordisk
,
JNJ
,
drug pricing
5 of the best places to work in pharma, according to employees
Pharma Voice
Tue, 08/29/23 - 11:32 am
Tags:
Glassdoor
,
Merck
,
JNJ
,
Pfizer
,
GSK
,
Sanofi
J&J ends R&D at Janssen's infectious disease and vaccine unit
Fierce Biotech
Wed, 08/23/23 - 05:40 pm
Tags:
JNJ
,
infectious disease
,
vaccines
,
R&D
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
Tags:
patent cliff
,
patents
,
Takeda
,
Vyvanse
,
Pfizer
,
Eraxis
,
JNJ
,
Stelara
,
Merck
,
Isentress
,
Eiger Pharmaceuticals
,
Zokinvy
,
Astellas
,
Myrbetriq
,
Novartis
,
Entresto
,
Amgen
,
Otzela
Regeneron, J&J Win HHS Funding to Develop Next-Gen COVID Products
BioSpace
Wed, 08/23/23 - 09:54 am
Tags:
HHS
,
Regeneron
,
JNJ
,
COVID-19
,
funding
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
Tags:
earnings
,
Eli Lilly
,
JNJ
,
Novo Nordisk
,
Novartis
,
AstraZeneca
Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation
Medical Devices and Diagnostics Industry
Tue, 08/22/23 - 09:56 am
Tags:
JNJ
,
Medtech
,
Biosense Webster
,
FDA
,
cardiac ablation
Janssen granted additional European Commission approval for bispecific antibody
Biopharma Reporter
Tue, 08/22/23 - 09:54 am
Tags:
Janssen
,
JNJ
,
bispecific antibodies
,
Europe
,
relapsed or refractory multiple myeloma
Johnson & Johnson to keep a 9.5% stake in consumer health spinoff Kenvue stake after exchange offer
Fierce Pharma
Mon, 08/21/23 - 06:55 pm
Tags:
JNJ
,
consumer health
,
spinoff
,
Kenvue
J&J’s Abiomed updates labeling for certain Impella heart pumps in Class I safety event
Fierce Biotech
Sun, 08/20/23 - 05:15 pm
Tags:
Medtech
,
JNJ
,
Abiomed
,
Impella
,
product recalls
,
device recalls
J&J joins PARP rivals with narrow FDA clearance in prostate cancer
BioPharma Dive
Mon, 08/14/23 - 10:18 am
Tags:
JNJ
,
Akeega
,
BRCA-mutated prostate cancer
,
PARP inhibitors
,
FDA
J&J bags first FDA approval for a GPRC5D drug
Pharmaphorum
Thu, 08/10/23 - 09:52 am
Tags:
JNJ
,
FDA
,
GPRC5D
,
Talvey
,
relapsed or refractory multiple myeloma
Johnson & Johnson's Talc Problems Aren't Going Away
Motley Fool
Wed, 08/9/23 - 10:05 am
Tags:
JNJ
,
talc
,
legal
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
Mon, 08/7/23 - 10:52 am
Tags:
JNJ
,
Stelara
,
patents
,
legal
,
Formycon
,
Fresenius Kabi
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
Tags:
clinical trials
,
Sarepta Therapeutics
,
DMD
,
Elevidys
,
Bridge Bio
,
ATTR-CM
,
acoramidis
,
Sanofi
,
Merck KGaA
,
MS
,
tolebrutinib
,
Pfizer
,
obesity
,
danuglipron
,
Novo Nordisk
,
Ozempic
,
Verve Therapeutics
,
heterozygous familial hypercholesterolemia
,
Roche
,
lung cancer
,
tiragolumab
,
Vertex Pharmaceutical
,
VS-548
,
pain
,
JNJ
,
Bristol Myers Squibb
Abiomed’s Impella Now Linked to 4 Deaths in Recent Recall
Medical Devices and Diagnostics Industry
Sun, 08/6/23 - 09:31 pm
Tags:
Medtech
,
Abiomed
,
JNJ
,
Impella
,
TAVR
,
patient deaths
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
Tags:
injectables
,
cancer
,
JNJ
,
Bristol Myers Squibb
,
Halozyme
,
drug pricing
Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Tags:
Big Pharma
,
Pharma CEOs
,
drug pricing
,
M&A
,
JNJ
,
Merck
,
GSK
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Fierce Pharma
Wed, 07/26/23 - 06:37 pm
Tags:
JNJ
,
Alkermes
,
oncology
,
earnings
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
Tags:
JNJ
,
GSK
,
ViiV
,
Gilead Sciences
,
HIV
,
Cabenuva
,
Biktarvy
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.